JP2009540801A5 - - Google Patents

Download PDF

Info

Publication number
JP2009540801A5
JP2009540801A5 JP2009515579A JP2009515579A JP2009540801A5 JP 2009540801 A5 JP2009540801 A5 JP 2009540801A5 JP 2009515579 A JP2009515579 A JP 2009515579A JP 2009515579 A JP2009515579 A JP 2009515579A JP 2009540801 A5 JP2009540801 A5 JP 2009540801A5
Authority
JP
Japan
Prior art keywords
polypeptide
amino acid
seq
fragment
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009515579A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009540801A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/070755 external-priority patent/WO2007149715A2/en
Publication of JP2009540801A publication Critical patent/JP2009540801A/ja
Publication of JP2009540801A5 publication Critical patent/JP2009540801A5/ja
Pending legal-status Critical Current

Links

JP2009515579A 2006-06-16 2007-06-08 トリインフルエンザ赤血球凝集素の新規なdna配列、ベクターおよびタンパク質 Pending JP2009540801A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81424106P 2006-06-16 2006-06-16
PCT/US2007/070755 WO2007149715A2 (en) 2006-06-16 2007-06-08 Novel dna sequences, vectors and proteins of avian influenza hemagglutinin

Publications (2)

Publication Number Publication Date
JP2009540801A JP2009540801A (ja) 2009-11-26
JP2009540801A5 true JP2009540801A5 (enExample) 2010-07-22

Family

ID=38834237

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009515579A Pending JP2009540801A (ja) 2006-06-16 2007-06-08 トリインフルエンザ赤血球凝集素の新規なdna配列、ベクターおよびタンパク質

Country Status (11)

Country Link
US (1) US8163876B2 (enExample)
EP (1) EP2029167A4 (enExample)
JP (1) JP2009540801A (enExample)
KR (1) KR20090027216A (enExample)
CN (1) CN101472607A (enExample)
AR (1) AR061484A1 (enExample)
AU (1) AU2007261196A1 (enExample)
BR (1) BRPI0713671A2 (enExample)
CA (1) CA2654178A1 (enExample)
WO (1) WO2007149715A2 (enExample)
ZA (1) ZA200808845B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1833030B (zh) 2003-05-22 2014-07-23 美国弗劳恩霍夫股份有限公司 用于表达、传递及纯化目标多肽的重组载体分子
EP1919504B1 (en) 2005-08-03 2013-10-16 iBio, Inc. Antibody to bacillus anthracis protective antigen
JP2009540801A (ja) * 2006-06-16 2009-11-26 ダウ・アグロサイエンス・エル・エル・シー トリインフルエンザ赤血球凝集素の新規なdna配列、ベクターおよびタンパク質
EP2092059A4 (en) 2006-10-24 2012-03-28 Bogoch Samuel METHOD FOR FORECASTING INFLUENZA EXCESSIONS BY CORRELATION OF AN INCREASED REPLICINE MIRROR IN WHITE SPOT AND / OR TAURA VIRUSES IN CRABES
MX2009013091A (es) 2007-05-30 2010-07-30 Bogoch Samuel Peptidos de repliquina sinteticos contra infeccion patogenica de invertebrados en acuicultura.
US8404252B2 (en) 2007-07-11 2013-03-26 Fraunhofer Usa, Inc. Yersinia pestis antigens, vaccine compositions, and related methods
EP2300493A2 (en) * 2008-04-23 2011-03-30 Samuel Bogoch Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles
DK2318530T3 (en) * 2008-07-18 2016-10-03 Medicago Inc Ny epitope to immunization against influenza
US20120034253A1 (en) * 2008-09-25 2012-02-09 Fraunhofer Usa, Inc. Influenza Vaccines, Antigens, Compositions, and Methods
WO2010037046A1 (en) 2008-09-28 2010-04-01 Fraunhofer Usa, Inc. Humanized neuraminidase antibody and methods of use thereof
US9233148B2 (en) 2009-01-09 2016-01-12 Samuel Bogoch Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
EP2421546A1 (en) * 2009-04-23 2012-02-29 Samuel Bogoch Replikin-sequences for preventing/treating influenza and determining infectivity/lethality
US8784819B2 (en) 2009-09-29 2014-07-22 Ibio Inc. Influenza hemagglutinin antibodies, compositions and related methods
CN101693894B (zh) * 2009-10-15 2011-07-27 北京大学深圳研究生院 禽流感病毒h5n1假病毒及其制备方法与专用dna片段
AR083533A1 (es) * 2010-10-22 2013-03-06 Boehringer Ingelheim Vetmed Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe
CA2842345A1 (en) 2011-07-20 2013-01-24 Samuel Bogoch Peptides shared among lethal cancers and therapeutic compositions comprising said peptides
RU2682752C2 (ru) * 2011-09-30 2019-03-21 Медикаго Инк. Повышение выхода вирусоподобных частиц в растениях
US9969794B2 (en) 2012-05-10 2018-05-15 Visterra, Inc. HA binding agents
RU2531235C2 (ru) 2013-02-15 2014-10-20 Общество с ограниченной ответственностью "Универсальные БиоСистемы" (ООО "УБС") Поливалентная вакцина против гриппа на основе гибридного белка
WO2015048129A1 (en) * 2013-09-24 2015-04-02 CHOI, Duk, Kyung Avian influenza virus polypeptides and methods of their use
WO2017083627A1 (en) 2015-11-13 2017-05-18 Visterra, Inc. Compositions and methods for treating and preventing influenza
CA3015347A1 (en) 2016-02-24 2017-08-31 Visterra, Inc. Formulations of antibody molecules to influenza virus
GB2578163A (en) * 2018-10-19 2020-04-22 Univ Pretoria Plant produced avian influenza antigens and their uses in diagnostic assays and devices
EP3946613A1 (en) 2019-03-25 2022-02-09 Visterra, Inc. Compositions and methods for treating and preventing influenza
US20240191245A1 (en) * 2021-03-18 2024-06-13 Calyxt, Inc. Plant cell matrices and methods thereof
CA3230289A1 (en) * 2021-08-30 2023-03-09 Japan Eco-Science Co., Ltd. Immunostimulatory preparation and cosmetic, food, feed additive, and quasi-pharmaceutical product containing the immunostimulatory preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060035596A (ko) * 2003-05-05 2006-04-26 보이스 톰슨 인스터튜트 포 플랜트 리서치 외래유전자도입 식물로부터 유래된 면역보호성 조성물을제조하기 위한 벡터와 세포
WO2005116260A2 (en) * 2004-05-25 2005-12-08 Medimmune Vaccines, Inc. Influenza hemagglutinin and neuraminidase variants
JP2009535306A (ja) 2006-04-21 2009-10-01 ダウ・アグロサイエンス・エル・エル・シー 鳥インフルエンザに対するワクチンおよび使用方法
JP2009540801A (ja) * 2006-06-16 2009-11-26 ダウ・アグロサイエンス・エル・エル・シー トリインフルエンザ赤血球凝集素の新規なdna配列、ベクターおよびタンパク質

Similar Documents

Publication Publication Date Title
JP2022023102A (ja) 新規多価ナノ粒子に基づくワクチン
JP2009544333A5 (enExample)
JP2017503482A5 (enExample)
JP2007516696A5 (enExample)
JP2014507146A5 (enExample)
JP2016503655A5 (enExample)
RU2011104999A (ru) Варианты гемагглютинина и нейрамидазы вируса гриппа
JP2019506175A5 (enExample)
CN101065145B (zh) 嵌合g蛋白基狂犬疫苗
CN101820903A (zh) 预防性和治疗性流感疫苗、抗原、组合物和方法
WO2005024039B1 (en) Improved method for generating influenza viruses and vaccines
JP2014504851A5 (enExample)
HRP20100240T1 (hr) Polipeptidi za indukciju zaštitnog imunitetnog odgovora protiv staphylococcus aureus
WO2007149715A3 (en) Novel dna sequences, vectors and proteins of avian influenza hemagglutinin
JP2012516140A5 (enExample)
JP2014519817A5 (enExample)
KR101919002B1 (ko) 구제역 바이러스의 가용성 다가 항원단백질 및 이의 용도
CN115427071A (zh) 包含ltb和病原性抗原的组合物及其用途
JP2008545393A5 (enExample)
JP2020509770A5 (enExample)
JP2020502075A5 (enExample)
JP2018533908A5 (enExample)
KR102647829B1 (ko) 삼량체를 형성하는 코로나-19 바이러스 (COVID-19, Coronavirus Disease 2019)의 재조합 스파이크 단백질 및 식물에서의 상기 재조합 스파이크 단백질의 대량 생산 방법과 이를 기반으로하는 백신조성물 제조 방법
JP2010514698A5 (enExample)
JP2009501012A5 (enExample)